Drug Resistance Updates
Volume 14, Issue 6 , Pages 251-259 , December 2011

Slipping and sliding: Frameshift mutations in herpes simplex virus thymidine kinase and drug-resistance

Received 1 November 2010 ,Revised 14 August 2011 ,Accepted 18 August 2011.

References 

  1. Atkins JF, Baranov PV, Fayet O, Herr AJ, Howard MT, Ivanov IP, et al. Overriding standard decoding: implications of recoding for ribosome function and enrichment of gene expression. Cold Spring Harb. Symp. Quant. Biol. 2001;66:217–232
  2. Bacon TH, Boon RJ, Schultz M, Hodges-Savola C. Surveillance for antiviral-agent-resistant herpes simplex virus in the general population with recurrent herpes labialis. Antimicrob. Agents Chemother. 2002;46:3042–3044
  3. Bacon TH, Levin MJ, Leary JJ, Sarisky RT, Sutton D. Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. Clin. Microbiol. Rev. 2003;16:114–128
  4. Baranov PV, Gesteland RF, Atkins JF. Recoding: translational bifurcations in gene expression. Gene. 2002;286:187–201
  5. Besecker MI, Furness CL, Coen DM, Griffiths A. Expression of extremely low levels of thymidine kinase from an acyclovir-resistant herpes simplex virus mutant support reactivation from latently infected mouse trigeminal ganglia. J. Virol. 2007;81:8356–8360
  6. Boon RJ, Bacon TH, Robey HL, Coleman TJ, Connolly A, Crosson P, et al. Antiviral susceptibilities of herpes simplex virus from immunocompetent subjects with recurrent herpes labialie: a UK-based survey. J. Antimicrob. Chemother. 2000;46:324–325
  7. Chappell SA, Edelman GM, Mauro VP. A 9-nt segment of a cellular mRNA can function as an internal ribosome entry site (IRES) and when present in linked multiple copies greatly enhances IRES activity. Proc. Natl. Acad. Sci. U.S.A. 2000;97:1536–1541
  8. Chatis PA, Crumpacker CS. Analysis of the thymidine kinase gene from clinically isolated acyclovir-resistant herpes simplex viruses. Virology. 1991;180:793–797
  9. Chen SH, Cook WJ, Grove KL, Coen DM. Human thymidine kinase can functionally replace herpes simplex virus type 1 thymidine kinase for viral replication in mouse sensory ganglia and reactivation from latency upon explant. J. Virol. 1998;72:6710–6715
  10. Chen SH, Lin YW, Griffiths A, Huang WY, Chen SH. Competition and complementation between thymidine kinase-negative and wild-type herpes simplex virus during co-infection of mouse trigeminal ganglia. J. Gen. Virol. 2006;87:3495–3502
  11. Chen Y, Scieux C, Garrait V, Socie G, Rocha V, Molina JM, et al. Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation. Clin. Infect. Dis. 2000;31:927–935
  12. Christophers J, Clayton J, Craske J, Ward R, Collins P, Trowbridge M, et al. Survey of resistance of herpes simplex virus to acyclovir in northwest England. Antimicrob. Agents Chemother. 1998;42:868–872
  13. Coen DM, Kosz Vnenchak M, Jacobson JG, Leib DA, Bogard CL, Schaffer PA, et al. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc. Natl. Acad. Sci. U.S.A. 1989;86:4736–4740
  14. Coen DM, Richman DD. Antiviral Agents. In:  Knipe DM,  Howley PM editor. Fields Virology. Philadelphia, PA: Lippincott Williams & Wilkins; 2007;p. 447–485
  15. Coen DM, Schaffer PA. Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1. Proc. Natl. Acad. Sci. U.S.A. 1980;77:2265–2269
  16. Collins P, Ellis MN. Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir. J. Med. Virol. 1993;1(Suppl):58–66
  17. Davar G, Kramer MF, Garber D, Roca AL, Andersen JK, Bebrin W, et al. Comparative efficacy of expression of genes delivered to mouse sensory neurons with herpes virus vectors. J. Comp. Neurol. 1994;339:3–11
  18. Davison KL, Crowcroft NS, Ramsay ME, Brown DW, Andrews NJ. Viral encephalitis in England, 1989–1998: what did we miss?. Emerg. Infect. Dis. 2003;9:234–240
  19. Efstathiou S, Kemp S, Darby G, Minson AC. The role of herpes simplex virus type 1 thymidine kinase in pathogenesis. J. Gen. Virol. 1989;70:869–879
  20. Elion GB, Furman PA, Fyfe JA, de Miranda P, Beauchamp L, Schaeffer HJ. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc. Natl. Acad. Sci. U.S.A. 1977;74:5716–5720
  21. Ellis MN, Waters R, Hill EL, Lobe DC, Selleseth DW, Barry DW. Orofacial infection of athymic mice with defined mixtures of acyclovir-susceptible and acyclovir-resistant herpes simplex virus type 1. Antimicrob. Agents Chemother. 1989;33:304–310
  22. Englund JA, Zimmerman ME, Swierkosz EM, Goodman JL, Scholl DR, Balfour HH. Herpes simplex virus resistant to acyclovir. A study in a tertiary care center. Ann. Intern. Med. 1990;112:416–422
  23. Field HJ. Development of clinical resistance to acyclovir in herpes simplex virus-infected mice receiving oral therapy. Antimicrob. Agents Chemother. 1982;21:744–752
  24. Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS. 2006;20:73–83
  25. Frobert E, Cortay JC, Ooka T, Najioullah F, Thouvenot D, Lina B, et al. Genotypic detection of acyclovir-resistant HSV-1: characterization of 67 ACV-sensitive and 14 ACV-resistant viruses. Antiviral Res. 2008;79:28–36
  26. Gaudreau A, Hill E, Balfour HH, Erice A, Boivin G. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients. J. Infect. Dis. 1998;178:297–303
  27. Gilbert C, Bestman-Smith J, Boivin G. Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms. Drug Resist. Updat. 2002;5:88–114
  28. Grey F, Sowa M, Collins P, Fenton RJ, Harris W, Snowden W, et al. Characterization of a neurovirulent aciclovir-resistant variant of herpes simplex virus. J. Gen. Virol. 2003;84:1403–1410
  29. Griffiths A, Chen SH, Horsburgh BC, Coen DM. Translational compensation of a frameshift mutation affecting herpes simplex virus thymidine kinase is sufficient to permit reactivation from latency. J. Virol. 2003;77:4703–4709
  30. Griffiths A, Coen DM. High-frequency phenotypic reversion and pathogenicity of an acyclovir-resistant herpes simplex virus mutant. J. Virol. 2003;77:2282–2286
  31. Griffiths A, Coen DM. An unusual internal ribosome entry site in the herpes simplex virus thymidine kinase gene. Proc. Natl. Acad. Sci. U.S.A. 2005;102:9667–9672
  32. Griffiths A, Link MA, Furness CL, Coen DM. Low-level expression and reversion both contribute to reactivation of herpes simplex virus drug-resistant mutants with mutations on homopolymeric sequences in thymidine kinase. J. Virol. 2006;80:6568–6574
  33. Gurvich OL, Baranov PV, Zhou J, Hammer AW, Gesteland RF, Atkins JF. Sequences that direct significant levels of frameshifting are frequent in coding regions of Escherichia coli. EMBO J. 2003;22:5941–5950
  34. Harris W, Collins P, Fenton RJ, Snowden W, Sowa M, Darby G. Phenotypic and genotypic characterization of clinical isolates of herpes simplex virus resistant to aciclovir. J. Gen. Virol. 2003;84:1393–1401
  35. Horsburgh BC, Chen SH, Hu A, Mulamba GB, Burns WH, Coen DM. Recurrent acyclovir-resistant herpes simplex in an immunocompromised patient: can strain differences compensate for loss of thymidine kinase in pathogenesis?. J. Infect. Dis. 1998;178:618–625
  36. Horsburgh BC, Kollmus H, Hauser H, Coen DM. Translational recoding induced by G-rich mRNA sequences that form unusual structures. Cell. 1996;86:949–959
  37. Hwang CB, Horsburgh BC, Pelosi E, Roberts S, Digard P, Coen DM. A net +1 frameshift permits synthesis of thymidine kinase from a drug-resistant herpes simplex virus mutant. Proc. Natl. Acad. Sci. U.S.A. 1994;91:5461–5465
  38. Juers DH, Jacobson RH, Wigley D, Zhang XJ, Huber RE, Tronrud DE, et al. High resolution refinement of beta-galactosidase in a new crystal form reveals multiple metal-binding sites and provides a structural basis for alpha-complementation. Protein Sci. 2000;9:1685–1699
  39. Kost RG, Hill EL, Tigges M, Straus SE. Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient. N. Engl. J. Med. 1993;329:1777–1782
  40. Kosz-Vnenchak M, Coen DM, Knipe DM. Restricted expression of herpes simplex virus lytic genes during establishment of latent infection by thymidine kinase-negative mutant viruses. J. Virol. 1990;64:5396–5402
  41. Kunkel TA, Bebenek K. DNA replication fidelity. Annu. Rev. Biochem. 2000;69:497–529
  42. Leist TP, Sandri-Goldin RM, Stevens JG. Latent infections in spinal ganglia with thymidine kinase-deficient herpes simplex virus. J. Virol. 1989;63:4976–4978
  43. Miller WH, Miller RL. Phosphorylation of acyclovir diphosphate by cellular enzymes. Biochem. Pharmacol. 1982;31:3879–3884
  44. Morfin F, Souillet G, Bilger K, Ooka T, Aymard M, Thouvenot D. Genetic characterization of thymidine kinase from acyclovir-resistant and -susceptible herpes simplex virus type 1 isolated from bone marrow transplant recipients. J. Infect. Dis. 2000;182:290–293
  45. Morfin F, Thouvenot D, Aymard M, Souillet G. Reactivation of acyclovir-resistant thymidine kinase-deficient herpes simplex virus harbouring single base insertion within a 7 Gs homopolymer repeat of the thymidine kinase gene. J. Med. Virol. 2000;62:247–250
  46. Namy O, Rousset JP, Napthine S, Brierley I. Reprogrammed genetic decoding in cellular gene expression. Mol. Cell. 2004;13:157–168
  47. Owens GC, Chappell SA, Mauro VP, Edelman GM. Identification of two short internal ribosome entry sites selected from libraries of random oligonucleotides. Proc. Natl. Acad. Sci. U.S.A. 2001;98:1471–1476
  48. Parris DS, Harrington JE. Herpes simplex virus variants resistant to high concentrations of acyclovir exist in clinical isolates. Antimicrob. Agents Chemother. 1982;22:71–77
  49. Pelletier J, Sonenberg N. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature. 1988;334:320–325
  50. Roizman B, Knipe DM, Whitley RJ. Herpes simplex viruses. In:  Knipe DM,  Howley PM editor. Fields Virology. Philadelphia, PA: Lippincott Williams & Wilkins; 2007;p. 2502–2601
  51. Sacks SL, Wanklin RJ, Reece DE, Hicks KA, Tyler KL, Coen DM. Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity?. Ann. Intern. Med. 1989;111:893–899
  52. Sarisky RT, Quail MR, Clark PE, Nguyen TT, Halsey WS, Wittrock RJ, et al. Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir. J. Virol. 2001;75:1761–1769
  53. Sasadeusz JJ, Sacks SL. Spontaneous reactivation of thymidine kinase-deficient, acyclovir-resistant type-2 herpes simplex virus: masked heterogeneity or reversion?. J. Infect. Dis. 1996;174:476–482
  54. Sasadeusz JJ, Tufaro F, Safrin S, Schubert K, Hubinette MM, Cheung PK, et al. Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovir. J. Virol. 1997;71:3872–3878
  55. Schmit I, Boivin G. Characterization of the DNA polymerase and thymidine kinase genes of herpes simplex virus isolates from AIDS patients in whom acyclovir and foscarnet therapy sequentially failed. J. Infect. Dis. 1999;180:487–490
  56. Shah AA, Giddings MC, Parvaz JB, Gesteland RF, Atkins JF, Ivanov IP. Computational identification of putative programmed translational frameshift sites. Bioinformatics. 2002;18:1046–1053
  57. Stranska R, Schuurman R, Nienhuis E, Goedegebuure IW, Polman M, Weel JF, et al. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization. J. Clin. Virol. 2005;32:7–18
  58. Summers WC, Summers WP. [125I]deoxycytidine used in a rapid, sensitive, and specific assay for herpes simplex virus type 1 thymidine kinase. J. Virol. 1977;24:314–318
  59. Swetter SM, Hill EL, Kern ER, Koelle DM, Posavad CM, Lawrence W, et al. Chronic vulvar ulceration in an immunocompetent woman due to acyclovir-resistant, thymidine kinase-deficient herpes simplex virus. J. Infect. Dis. 1998;177:543–550
  60. Tenser RB, Hay KA, Edris WA. Latency-associated transcript but not reactivatable virus is present in sensory ganglion neurons after inoculation of thymidine kinase-negative mutants of herpes simplex virus type 1. J. Virol. 1989;63:2861–2865
  61. Thompson RL, Sawtell NM. Replication of herpes simplex virus type 1 within trigeminal ganglia is required for high frequency but not high viral genome copy number latency. J. Virol. 2000;74:965–974
  62. Ullmann A, Perrin D, Jacob F, Monod J. [Identification, by in vitro complementation and purification, of a peptide fraction of Escherichia coli beta-galactosidase]. J. Mol. Biol. 1965;12:918–923
  63. Wade JC, McLaren C, Meyers JD. Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir. J. Infect. Dis. 1983;148:1077–1082
  64. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J. Infect. Dis. 2002;185:45–52
  65. Wald A, Zeh J, Selke S, Ashley RL, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N. Engl. J. Med. 1995;333:770–775
  66. Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, Nahmias AJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. J. Am. Med. Assoc. 2006;296:964–973
  67. Zhu J, Hladik F, Woodward A, Klock A, Peng T, Johnston C, et al. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat. Med. 2009;15:886–892
  68. Zook MB, Howard MT, Sinnathamby G, Atkins JF, Eisenlohr LC. Epitopes derived by incidental translational frameshifting give rise to a protective CTL response. J. Immunol. 2006;176:6928–6934

PII: S1368-7646(11)00062-8

doi: 10.1016/j.drup.2011.08.003

Drug Resistance Updates
Volume 14, Issue 6 , Pages 251-259 , December 2011

Article Tools

* Image Usage & Resolution